Publications by authors named "Jacqueline Hui Yi Wong"
Article Synopsis
- * Through interviews with 26 patients, four main themes emerged: desired treatment outcomes, side effects impacting quality of life, accessibility of treatments, and financial considerations.
- * The findings indicate that patients prioritize treatments that maximize survival and quality of life while being mindful of costs, often favoring options supported by government funding or insurance.
Background: Optimizing efficiency has become increasingly critical with the growing demand for finite healthcare resources driven by population growth and an ageing society. Hence, policymakers are urgently finding more efficient ways to deliver health services. Thalassemia is a complex inherited blood disorder with significant prevalence in Malaysia.
View Article and Find Full Text PDFPurpose: To develop a mapping algorithm for generating EQ-5D-3L utility scores from the PedsQL Generic Core Scales (PedsQL GCS) in patients with transfusion-dependent thalassemia (TDT).
Methods: The algorithm was developed using data from 345 TDT patients. Spearman's rank correlation was used to evaluate the conceptual overlap between the instruments.
Article Synopsis
- Transfusion-dependent thalassaemia (TDT) is a genetic blood disorder requiring frequent blood transfusions and iron-chelating therapy to manage complications and enhance patients' quality of life.
- A study in Malaysia estimated the lifetime cost for a TDT patient at approximately USD 606,665, with the majority of costs coming from iron-chelating therapy (56.9%) and blood transfusions (13.1%).
- Factors like the frequency of healthcare visits and specific treatment types significantly influence the financial burden on both patients and their families.
Purpose: There is a gap of information describing the health state utility values (HSUVs) of transfusion-dependent thalassemia (TDT) patients in Malaysia. These values are useful in the assessment of health-related quality of life (HRQoL), economic evaluations and provide guidance to disease management decisions. The objective of this study was to estimate and derive HSUVs associated with the treatment and complications of TDT patients in Malaysia using the EQ-5D-3L instrument.
View Article and Find Full Text PDFBackground: The treatment of children with transfusion-dependent thalassemia (TDT) in Malaysia has progressed since 2005. This study provides an updated health-related quality of life (HRQoL) assessment for children with the disorder and the factors affecting the HRQoL.
Methods: A cross-sectional HRQoL survey of Malaysian children with TDT was conducted using the PedsQL™ 4.